| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/22/2012 | EP2419095A2 Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses |
| 02/22/2012 | EP2419010A1 Targeted detection of dysplasia in barrett's esophagus with a novel fluorescence-labeled polypeptide |
| 02/22/2012 | EP1799268B1 Magnetic particles for therapy and diagnosis |
| 02/22/2012 | EP1615558B1 Method for the spatially resolved determination of physical, chemical and biological properties or state variables |
| 02/22/2012 | EP1494721B1 Cavity filling biopsy site marker |
| 02/22/2012 | CN102358905A Bioluminescent reporter gene for monitoring DNA (Deoxyribonucleic Acid) synthesis phase and application thereof |
| 02/22/2012 | CN102358752A GLP-1 and exendin related invention |
| 02/22/2012 | CN102357250A Magnetic resonance imaging (MRI)-oriented high intensity focused ultrasound (HIFU) synergist and preparation method thereof |
| 02/22/2012 | CN101698105B 胃肠道造影剂 Gastrointestinal contrast agent |
| 02/22/2012 | CN101241788B 在生理缓冲液中能够高度溶解并稳定分散的生物相容性磁性纳米晶体及其制备方法 Biocompatible magnetic nanocrystals in a physiological buffer solution can be highly soluble and stable dispersion and its preparation method |
| 02/21/2012 | US8119402 Methods of inhibiting T1R1/T1R3 heteromeric umami taste receptors |
| 02/21/2012 | US8119104 Treatment of celiac disease with IgA |
| 02/21/2012 | US8119103 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 02/21/2012 | CA2264592C Bioconjugates and delivery of bioactive agents |
| 02/16/2012 | WO2012021800A2 Caspase inhibitors as therapeutics for neural and organ injury and imaging |
| 02/16/2012 | WO2012021788A2 Dipeptide calpain inhibitors |
| 02/16/2012 | WO2012021046A2 Radial shape of polymer compound containing iodine, preparation method thereof, and ct contrast medium composition containing same |
| 02/16/2012 | WO2012020337A1 Polymerized micelles for diagnosis |
| 02/16/2012 | WO2012020030A1 Targeted gas-filled microvesicles |
| 02/16/2012 | WO2012019619A1 Fluorescent proteins with increased activity in cells |
| 02/16/2012 | WO2012019300A1 Endometrial cancer biomarkers and methods of identifying and using same |
| 02/16/2012 | WO2011160216A3 Compounds useful in imaging and therapy |
| 02/16/2012 | WO2011143360A3 Compositions, methods and systems for the synthesis and use of imaging agents |
| 02/16/2012 | WO2011141766A8 Ferritin biosensor and methods of using the same |
| 02/16/2012 | WO2011131693A3 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| 02/16/2012 | US20120042398 Compositions for labeling and identifying autophagosomes and methods for making and using them |
| 02/16/2012 | US20120041915 Method for diagnosing urticaria and angioedema |
| 02/16/2012 | US20120041357 Method of controlled drug release from a liposome carrier |
| 02/16/2012 | US20120041303 Phage antibodies to radiation-inducible neoantigens |
| 02/16/2012 | US20120039885 Composition and method for cancer treatment |
| 02/16/2012 | US20120039816 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
| 02/16/2012 | US20120039815 Contrast agents |
| 02/16/2012 | US20120039814 Topical Compositions and Methods of Detection and Treatment |
| 02/16/2012 | US20120039813 Intrinsically colored, luminescent silk fibroin and a method of producing the same |
| 02/16/2012 | US20120039812 Genes associated with posttraumatic-stress disorder (ptsd) |
| 02/16/2012 | US20120039811 Markers for cancer detection |
| 02/16/2012 | US20120039810 Aptamer-containing compositions and methods for targeting e-selectin |
| 02/16/2012 | US20120039809 Systems and techniques for monitoring subjects |
| 02/16/2012 | US20120039808 Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor |
| 02/16/2012 | US20120039807 Anti-Tenascin-C A2 Antibodies and Methods of Use |
| 02/16/2012 | US20120039806 Compounds and Methods for Modulating an Immune Response |
| 02/16/2012 | US20120039805 Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample |
| 02/16/2012 | US20120039804 Novel Tricyclic Modulators of Cannabinoid Receptors |
| 02/16/2012 | US20120039803 Pretargeting kit, method and agents used therein |
| 02/16/2012 | US20120039802 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 02/16/2012 | US20120039801 SPARC binding peptides and uses thereof |
| 02/16/2012 | DE102010034496A1 Photosensiver molekularer Schalter mit einem Chelat-Liganden und isomerisierbarem photochromem System Photosensiver molecular switch with a chelate ligand and isomerizable photochromic system |
| 02/16/2012 | DE102010034256A1 Luminescent substance exhibiting a host lattice doped with a luminescent activator, useful in a diagnostic or therapeutic method or a tissue labeling method in vivo or in vitro, where the diagnostic method is graphical angiographic method |
| 02/16/2012 | DE102004045186B9 Liposomen, die die intrazelluläre Penetration von Wirkstoffen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of active substances, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration |
| 02/16/2012 | CA2807587A1 Fluorescent proteins with increased activity in cells |
| 02/16/2012 | CA2806639A1 Targeted gas-filled microvesicles |
| 02/15/2012 | EP2417457A1 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma |
| 02/15/2012 | EP2416806A1 Fucoidans as ligands for the diagnosis of degenerative pathologies |
| 02/15/2012 | EP1627395B1 Aqueous dispersions stable in neutral media, comprising surface-modified particles |
| 02/15/2012 | CN102350277A Composite microballoon with functions of dual mode imaging and photodynamic activity and preparation method thereof |
| 02/15/2012 | CN102350002A Glioma-targeting molecule magnetic resonance contrast agent as well as preparation method and application thereof |
| 02/15/2012 | CN101862460B 一种消毒灭菌型医用超声耦合剂及其制备方法 A sterile medical ultrasound coupling agent type and preparation method disinfection |
| 02/15/2012 | CN101716348B 一种基于金磁纳米粒子的载药平台的构建与应用 Construction and Application of gold based on magnetic nanoparticles drug loading platform |
| 02/14/2012 | US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 |
| 02/14/2012 | US8114384 Process for the production of an abuse-proofed solid dosage form |
| 02/14/2012 | US8114383 Abuse-proofed dosage form |
| 02/14/2012 | US8114382 Myelin detection using benzofuran derivatives |
| 02/14/2012 | US8114379 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 02/09/2012 | WO2012019145A1 Radiopaque shape memory polymers for medical devices |
| 02/09/2012 | WO2012018790A2 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | WO2012018290A1 Discrete coated nanoparticles |
| 02/09/2012 | WO2012018240A2 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 02/09/2012 | US20120034170 Nanobubbles Useful As An Ultrasonic Contrast Agent For The Lymphatic System |
| 02/09/2012 | US20120034169 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/09/2012 | US20120034168 Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof |
| 02/09/2012 | US20120034167 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer |
| 02/09/2012 | US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 02/09/2012 | US20120034164 Truncated car peptides and methods and compositions using truncated car peptides |
| 02/09/2012 | US20120034160 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | US20120034158 Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis corresponding compositions and kits |
| 02/09/2012 | US20120034157 Artificial cells |
| 02/09/2012 | US20120034155 Artificial cells |
| 02/09/2012 | CA2807149A1 Novel treatment of prostate carcinoma |
| 02/09/2012 | CA2797101A1 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 02/08/2012 | EP2415487A1 An ultrasonic couplant composition and methods for producing |
| 02/08/2012 | EP2413976A1 Optical imaging agents |
| 02/08/2012 | EP2413975A1 Lipopeptide inhibitors of hiv-1 |
| 02/08/2012 | EP2413972A1 Bonding products of aminated polysaccharides |
| 02/08/2012 | EP2222346B1 Mr imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used |
| 02/08/2012 | CN102344494A Nicotinamide adenine dinucleotide gene coding fluorescent probe as well as preparation method and application thereof |
| 02/08/2012 | CN102343103A Screening and verifying of human papilloma virus (HPV) 16 tripeptide vaccine and construction of tumor animal model for continually expressing HPV16 E5, E6 and E7 |
| 02/08/2012 | CN102343098A Functionalized magnetic nanoparticles and methods of use thereof |
| 02/08/2012 | CN101711871B 银纳米链网状材料及制备方法和在制备治疗肿瘤药物中的应用 Nano silver chain mesh material and preparation method and application in the manufacture of a medicament for the treatment of cancer |
| 02/07/2012 | US8110554 Peptides whose uptake by cells is controllable |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/07/2012 | CA2452923C Peptide-based compounds for targeting integrin receptors |
| 02/07/2012 | CA2333147C Cancer treatment methods using antibodies to aminophospholipids |
| 02/02/2012 | WO2012015125A1 Stimulus sensitive magnetic nanocomposite using pyrene polymer, and contrast medium composition containing the nanocomposite |
| 02/02/2012 | WO2012014163A1 An antigen specific ultrasound contrast medium, a process for the preparation thereof and its uses |
| 02/02/2012 | WO2012013247A1 Measurement method for determining an organ function |
| 02/02/2012 | WO2011156895A3 Porous magnetic nanoparticles and uses thereof formed by incomplete hydrolysis |
| 02/02/2012 | WO2011135580A3 Pharmaceutical compositions of sirolimus |
| 02/02/2012 | WO2011109214A3 Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same |
| 02/02/2012 | WO2011105736A3 Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for x-ray computed tomography and highly dielectric thin film using same |